靶向色氨酸代谢通路整合PK-PD关联分析的逍遥散治疗肝郁脾虚型抑郁症的体内药效物质研究
批准号:
82003914
项目类别:
青年科学基金项目
资助金额:
24.0 万元
负责人:
何亮亮
依托单位:
学科分类:
中药药效物质
结题年份:
2023
批准年份:
2020
项目状态:
已结题
项目参与者:
何亮亮
中文摘要
抑郁症预计到2030年将成为世界第一大负担疾病,但其现代医药治疗存在局限。疏肝健脾中药经典方逍遥散改善抑郁症的临床疗效确切且安全,但体内药效物质不清。为此,本研究在前期已成功建立肝郁脾虚型抑郁大鼠模型及成熟的生物学评价体系基础上,提出中医“病-证结合、方-证相关”指导下的外源物PK-内源物PD靶向动态关联分析策略;通过表征逍遥散在模型动物体内的外源性药效候选成分的动力学特征,并靶向描绘与抑郁症密切相关的色氨酸代谢通路中内源性成分的动态变化规律,建立PK-PD关联分析,发掘逍遥散体内潜在药效物质;结合网络药理学和细胞活性评价的药效辅助验证,尝试揭示逍遥散治疗肝郁脾虚型抑郁症的体内药效物质。上述研究有助于诠释逍遥散为何能发挥抗抑郁作用的科学内涵,有望为其质量标准的提升、临床合理应用,乃至相关创新药物研发提供科学依据,也可能作为研究示范为中药复方的体内药效物质研究提供有价值的思路借鉴。
英文摘要
Depression is estimated to become the world's largest burden disease by 2030, but its modern medical treatment has limitations. Xiaoyaosan (XYS), a classic Traditional Chinese Medicine (TCM) prescription for soothing liver and strengthening spleen, has a significant clinical effect on improving depression symptoms, but the corresponding in vivo pharmacodynamic ingredients are still unclear. In view of this, based on the successful establishment of a depressive rat model of liver stagnation and spleen deficiency syndrome and the mature biological evaluation system in the previous study, this study proposes a strategy of targeted dynamic correlation analysis of pharmacokinetics (PK) of exogenous components - pharmacodynamics (PD) of endogenous components under the guidance of “combination of disease-syndrome,correlation of formula-syndrome” of TCM. By describing the PK characteristics of the exogenous pharmacodynamic candidate components of XYS in model animals and targeting to characterize the dynamic changes of the endogenous components of tryptophan metabolic pathway closely related to depression, the PK-PD correlation analysis will be applied to explore the potential in vivo effective ingredients of XYS. Combined with the efficacy-assisted verification of network pharmacology and cell activity evaluation, this study is attempted to reveal the in vivo pharmacodynamic ingredients of XYS in the treatment of depression of the liver stagnation and spleen deficiency syndrome. Taken together, this study will be helpful to explain the scientific connotation of why XYS can play an antidepressant effect, and is expected to provide a reliable scientific basis for improving its quality standard, clinical reasonable application, and even the researches for development of related innovative drugs, and it may also provide an idea as a reference example for revealing the bioactive ingredients of other classical TCM prescriptions.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
DOI:
10.1016/j.phymed.2022.154511
发表时间:
2022-10
期刊:
Phytomedicine : international journal of phytotherapy and phytopharmacology
影响因子:
--
作者:
[Qi Wang;Guotao Chen;Xintong Chen;Yuehe Liu;Zifei Qin;P. Lin;Hongcai Shang;Min Ye;]
通讯作者:
Qi Wang;Guotao Chen;Xintong Chen;Yuehe Liu;Zifei Qin;P. Lin;Hongcai Shang;Min Ye;
DOI:
10.1039/d2ra06184h
发表时间:
2023
期刊:
RSC Advances
影响因子:
3.9
作者:
[Chanjuan Chen, Xintong Chen, Qingmei Mo, Jie Liu, Xinsheng Yao, Xin Di, Zifei Qin, Liangliang He, Zhihong Yao]
通讯作者:
Zhihong Yao
The discovery of Q-markers of Qiliqiangxin Capsule, a traditional Chinese medicine prescription in the treatment of chronic heart failure, based on a novel strategy of multi-dimensional "radar chart" mode evaluation
基于多维度“雷达图”模式评价新策略发现芪苈强心胶囊Q标记物治疗慢性心力衰竭
DOI:
10.1016/j.phymed.2020.153443
发表时间:
2021-01-08
期刊:
PHYTOMEDICINE
影响因子:
7.9
作者:
[He, Liangliang, Liu, Yuehe, Yao, Xinsheng]
通讯作者:
Yao, Xinsheng
DOI:
10.1016/j.chroma.2023.464045
发表时间:
2023-05-24
期刊:
JOURNAL OF CHROMATOGRAPHY A
影响因子:
4.1
作者:
[Zhu,Haodong, He,Liangliang, Yao,Zhihong]
通讯作者:
Yao,Zhihong
DOI:
10.1016/j.phymed.2023.155039
发表时间:
2023-09-04
期刊:
PHYTOMEDICINE
影响因子:
7.9
作者:
[Xia,Xichun, Zhang,Yingying, Huang,Jun-qing]
通讯作者:
Huang,Jun-qing
共 8 条
基于LC-MS的代谢循环分子网络快速揭示
中药物质基础及开源平台的构建: 以姜
科植物类中药为例
-
批准号:--
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:何亮亮
-
依托单位:
基于色氨酸“肠-脑”代谢网络平衡的逍遥散“多糖-小分子”协同改善肝郁脾虚型抑郁症的作用模式研究
-
批准号:--
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:何亮亮
-
依托单位:
国内基金
海外基金